Dermata Therapeutics, Inc. (DRMA) Current Reports & Earnings Releases
Upcoming
- 2026-11-13 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-17 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-08-11 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-08-05 | 8-K | Other Events | SEC |
| 2026-05-27 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-25 | 8-K | Officer / Director Changes | SEC |
| 2026-02-03 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2026-01-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-29 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-18 | 8-K | Termination of Agreement | SEC |
| 2025-11-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-11-07 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-17 | 8-K | Other Events | SEC |
| 2025-09-10 | 8-K | Other Events | SEC |
| 2025-08-25 | 8-K | Other Events | SEC |
| 2025-08-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-30 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-07-16 | 8-K | Shareholder Vote Results | SEC |
| 2025-07-07 | 8-K | Listing Notice | SEC |
| 2025-06-05 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-05-21 | 8-K | Reg FD Disclosure, Other Events | SEC |
| 2025-05-16 | 8-K | Listing Notice | SEC |
| 2025-05-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-15 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-28 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Financial Statements & Exhibits | SEC |
| 2025-03-27 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-25 | 8-K | Listing Notice | SEC |
| 2025-03-17 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-01-23 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-21 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-09-17 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-07 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-07 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-06-05 | 8-K | Other Events | SEC |
| 2024-05-24 | 8-K | Listing Notice | SEC |
| 2024-05-17 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Financial Statements & Exhibits | SEC |
| 2024-05-15 | 8-K | Listing Notice, Other Events | SEC |
| 2024-05-15 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-14 | 8-K | Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-05-07 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-03-21 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-12 | 8-K | Shareholder Vote Results | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.